Brennan-Krohn, Thea
- Beth Israel Deaconess Medical Center · Pathology (investigator's affiliation)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #24,846
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2018 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$484.4K
Full award amounts, FY2023
Award Records
1
Records listing this PI
Award-Linked Rank
#24,846
By linked amount among FY2023 PIs
Earliest Year Loaded
2018
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Brennan-Krohn, Thea as a PI. Multi-PI records show the full award amount for context.
- 1R01AI178875-01R01Contact PISusceptibility and resistance of multidrug-resistant gram-negative bacteria to novel beta-lactam/beta-lactamase inhibitor combinationsBeth Israel Deaconess Medical Center · Pathology (investigator's affiliation)$484.4Kaward amount
Award organization
Organizations that administered FY2023 awards listing Brennan-Krohn, Thea as a PI.
FY2023 award administered by Beth Israel Deaconess Medical Center (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2018First NIH AwardBeth Israel Deaconess Medical Center
- 2020$500K Cumulative Funding
- 2020R01 Grant Holder
- 2022$1M Cumulative Funding